Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of M72/AS01E Vaccine Against TB in Adults
NCT01755598Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2014
- Primary completion
- Nov 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of M72 + AS01E in pulmonary tuberculosis (TB), sponsored by GSK. Started Aug 2014; status: completed.
02
Drugs
M72 + AS01E
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT01755598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755598.